Hoping to bag the record Medibank dividend? Here's what you need to do

Time is running out if you'd like to bank the ASX 200 healthcare stock's largest-ever dividend.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last week, we covered the latest earnings results from Medibank Private Ltd (ASX: MPL) shares.

As we went through at the time, Medibank had some fairly positive numbers to showcase last Thursday.

The ASX 200 private health insurance giant reported a 3.3% rise in revenues to $4.02 billion. Underlying profit after tax rose by 16.3% to $262.5 million, while net profit after tax (NPAT) was up 104.8% to $491.9 million. Those figures were greatly assisted by a 49.6% increase in Medibank's net investment income to $83.6 million.

Investors didn't seem to like what they saw though. Since the day these announcements were made public, Medibank shares have fallen by more than 5%.

That's despite the company declaring a fully franked interim dividend of 7.2 cents per share for 2024.

Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

Everything you need to know about Medibank's upsized dividend

This was a fairly big announcement. For one, this dividend represents a healthy 14.3% rise over last year's equivalent interim payout of 6.3 cents per share. But it also happens to be the largest interim dividend that the company has ever paid out.

As we've already touched on, last year's interim dividend was worth 6.3 cents per share. 2022's payment came in at 6.1 cents.

Together with October's final dividend of 8.3 cents per share (also fully franked), Medibank's full-year dividends will now stretch from 14.6 cents per share to 15.5 cents.

However, if any investors out there who don't already own Medibank shares wish to receive this latest, upsized dividend, they are fast running out of time That's because Medibank shares are scheduled to trade ex-dividend this Thursday 29 February.

An ex-dividend date is when new investors in a company with an upcoming dividend are cut off from eligibility for the said dividend. So put another way, anyone who owns Medibank shares as of market close tomorrow is eligible to receive this Medibank dividend. But anyone who buys shares from Thursday onwards misses out.

As such, expect to see a significant drop in Medibank shares on Thursday morning, reflecting this inherent loss of value.

Dividend payday for those eligible Medibank shareholders will then roll around on 20 March next month.

Medibank is not currently running a dividend reinvestment plan (DRP). So investors have no alternative but to receive the traditional cash dividend payment.

Right now, Medibank shares are trading on a dividend yield of 4.25%, or 6.07% grossed-up with those full franking credits.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Young businesswoman sitting in kitchen and working on laptop.
Healthcare Shares

Up 15% in a week, is it too late to buy rebounding CSL shares?

CSL shares trade on roughly 13 times forecast FY26 earnings and offer a good dividend yield.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

Young woman thinking with laptop open.
Healthcare Shares

Why are Sigma Healthcare shares in the spotlight this week?

Is the latest sell-off overdone?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is it time to get greedy with Pro Medicus shares?

The company was swept up in the huge sector-wide downturn in late 2025 and early 2026 as investors turned their…

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development.
Healthcare Shares

Prediction: I think Telix shares could double in value in 2026. Here's why

The biopharmaceutical company's shares dipped to a three-year low in February, but have now rebounded strongly.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

How much does UBS think CSL will bounce back?

If the worst is over, what's the upside for the shares?

Read more »

Woman with long hair smiles for the camera.
Healthcare Shares

Why I'd buy CSL shares while sentiment is weak

The market no longer treats this ASX healthcare giant as flawless, and that may make the investment case more interesting.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Is this exciting healthcare stock a buy, hold or sell after rocketing 16% yesterday?

Can this soaring stock keep rising?

Read more »